Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thrombi-Gel for Lymphocele Prevention in Endometrial Cancer
NCT04205864Completed
- Sponsor
- Kocaeli University
- Start
- Dec 2019
- Primary completion
- Jul 2020
- Modality
- Implantable Devices, Transdermal Patches, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of gelatin + thrombin in lymphocele (2 arms), sponsored by Kocaeli University. Primary endpoint: Frequency of pelvic lymphocele at 2 months. Started Dec 2019; status: completed.
02
Drugs
gelatin + thrombin
03
Conditions
lymphocele
Beyond the preview
Go deeper on NCT04205864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04205864.